A patient with type 2 diabetes mellitus presents with an elevated HbA1c level of 9.2%, elevated LDL cholesterol, triglycerides, and has been diagnosed with mild non-proliferative diabetic retinopathy and diabetic neuropathy. Which of the following interventions should the nurse prioritize to address the multiple complications presented in this patient?

A) Initiate insulin therapy to rapidly reduce blood glucose levels.

B) Recommend a diet high in protein to manage kidney function.

C) Educate the patient on smoking cessation to reduce cardiovascular risks.

D) Coordinate a referral to an ophthalmologist for closer monitoring of retinopathy.

A 58-year-old female patient with a recent diagnosis of diabetic nephropathy and non-proliferative diabetic retinopathy presents for a follow-up visit. Her HbA1c is 9.2%, LDL cholesterol is 140 mg/dL, and triglycerides are 200 mg/dL. Which of the following nursing interventions is most appropriate to prioritize in her care plan to address her current condition and prevent further complications?

B) Initiate a referral to a dietitian for personalized meal planning to improve glycemic control and lipid levels.

A) Educate the patient on the importance of adhering to a low-sodium diet to manage her blood pressure.

B) Initiate a referral to a dietitian for personalized meal planning to improve glycemic control and lipid levels.

C) Recommend the patient increase her fluid intake to assist with kidney function.

D) Suggest over-the-counter omega-3 supplements to reduce triglyceride levels.

A patient with diabetes has been started on empagliflozin and atorvastatin. During a follow-up visit, the patient reports increased urinary frequency and persistent numbness in the feet. Which nursing intervention is most appropriate to address these concerns?

A) Educate the patient on the importance of hydration to prevent dehydration.

B) Instruct the patient to stop the empagliflozin immediately to reduce urinary frequency.

C) Advise the patient to increase dietary fiber intake to improve glycemic control.

D) Recommend the patient reduce physical activity to prevent further neuropathy.

A patient with diabetes mellitus has been started on empagliflozin and atorvastatin as part of her new treatment plan. During a follow-up visit, she reports increased urinary frequency and persistent numbness in her feet. Which of the following nursing interventions is most appropriate to address her current symptoms while considering her overall health management?

B) Instruct the patient on the importance of foot care and initiate gabapentin therapy.

A) Advise the patient to reduce fluid intake to manage urinary frequency.

B) Instruct the patient on the importance of foot care and initiate gabapentin therapy.

C) Recommend discontinuing empagliflozin due to its side effects.

D) Encourage the patient to increase physical activity to alleviate neuropathic symptoms.

A patient with diabetic nephropathy presents with new-onset fatigue, mild shortness of breath, and bilateral pedal edema. The patient's blood pressure is slightly elevated, and laboratory tests indicate decreased renal function. Which nursing intervention is most appropriate to prioritize in this situation?

B) Monitor the patient’s daily weights and report any significant changes to the healthcare provider.

A) Encourage the patient to increase their fluid intake to manage the pedal edema.

B) Monitor the patient’s daily weights and report any significant changes to the healthcare provider.

C) Instruct the patient to decrease their physical activity to reduce fatigue.

D) Advise the patient to increase dietary sodium to manage blood pressure.

A patient with a history of diabetic nephropathy presents with new onset fatigue, mild shortness of breath, and bilateral pedal edema, along with a slight increase in blood pressure. Her serum creatinine level has risen, and eGFR has decreased. Which nursing intervention is most appropriate to address her current symptoms and prevent further renal deterioration?

B) Educate the patient on the importance of reporting weight changes and worsening edema promptly.

A) Encourage the patient to increase fluid intake to counteract the effects of empagliflozin.

B) Educate the patient on the importance of reporting weight changes and worsening edema promptly.

C) Advise the patient to decrease protein intake significantly to reduce renal workload.

D) Suggest the patient temporarily discontinue her antihypertensive medications to prevent further kidney damage.

During the follow-up appointment, the nurse is reviewing the patient's home blood pressure and weight log. The patient mentions occasional mild shortness of breath during exertion and reports improvement in pedal edema. Given her current treatment plan that includes an ACE inhibitor and potential introduction of a low-dose diuretic, which nursing intervention is most appropriate to prioritize at this time?

B) Reinforce the importance of daily weight monitoring and sodium restriction.

A) Educate the patient on recognizing signs of hypotension.

B) Reinforce the importance of daily weight monitoring and sodium restriction.

C) Advise the patient to increase fluid intake to prevent dehydration.

D) Suggest reducing physical activity to minimize exertional symptoms.

A patient with diabetic nephropathy is on an ACE inhibitor and presents with a blood pressure of 140/88 mmHg and stabilized renal function. Which nursing intervention should be prioritized to enhance the patient's treatment plan?

B) Educate the patient on reducing sodium intake to manage fluid retention.

A) Increase the dose of the ACE inhibitor to improve blood pressure control.

B) Educate the patient on reducing sodium intake to manage fluid retention.

C) Recommend adding a calcium channel blocker to the medication regimen.

D) Advise the patient to stop monitoring her blood pressure at home.

A patient with diabetic nephropathy and hypertension is on an ACE inhibitor and a low-dose diuretic. Recent lab results show a serum potassium level of 5.2 mEq/L. Which nursing intervention is most appropriate to address the elevated potassium level while maintaining blood pressure control?

B) Advise the patient to avoid salt substitutes containing potassium.

A) Instruct the patient to increase intake of high-fiber foods to manage potassium levels.

B) Advise the patient to avoid salt substitutes containing potassium.

C) Recommend reducing fluid intake to prevent further electrolyte imbalance.

D) Suggest discontinuing the ACE inhibitor to immediately lower potassium levels.

A patient with hypertension and diabetic nephropathy is on an ACE inhibitor and a low-dose diuretic. Her serum potassium level is 5.2 mEq/L. What is the most appropriate nursing intervention to address the elevated potassium level?

B) Instruct the patient to report any signs of hyperkalemia such as muscle weakness or palpitations.

A) Encourage the patient to increase her intake of potassium-rich foods to balance her electrolytes.

B) Instruct the patient to report any signs of hyperkalemia such as muscle weakness or palpitations.

C) Advise the patient to discontinue the ACE inhibitor immediately until potassium levels normalize.

D) Suggest the patient increase water intake to dilute serum potassium levels.

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: In diabetes, either the pancreas produces insufficient insulin (Type 1) or the body's cells become resistant to insulin's effects (Type 2). Insulin is crucial for glucose uptake into cells for energy, leading to elevated blood glucose levels when dysfunctional.

• Secondary mechanism: Chronic hyperglycemia from impaired insulin function or resistance leads to glycation of proteins and lipids, damaging blood vessels and tissues. This process contributes to the development of microvascular complications like retinopathy, nephropathy, and neuropathy.

• Key complication: Persistent high blood glucose levels can lead to macrovascular complications, including cardiovascular diseases such as atherosclerosis, increasing the risk of heart attacks and strokes. Effective management of blood glucose is essential to minimize these risks.

Patient Profile

Demographics:

56-year-old female, office manager

History:

• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing numbness and tingling in feet

• Key symptoms: Fatigue, frequent urination, blurred vision, slow-healing sores on feet

• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, random blood glucose 240 mg/dL

Section 1

New Diagnostic Results:

Following the initial assessment, the healthcare team ordered a series of diagnostic tests to further evaluate the patient's condition and identify potential complications related to her diabetes. The results of the comprehensive metabolic panel revealed an elevated HbA1c level of 9.2%, indicating poor long-term blood glucose control. Additionally, a lipid profile showed elevated LDL cholesterol at 140 mg/dL and triglycerides at 200 mg/dL, suggesting suboptimal management of her hyperlipidemia. Furthermore, a microalbuminuria test was positive, with albumin levels at 45 mg/g creatinine, raising concerns about early diabetic nephropathy.

Concurrent with these laboratory findings, an ophthalmologic evaluation identified mild non-proliferative diabetic retinopathy, evidenced by microaneurysms and retinal hemorrhages. This underscores the need for immediate intervention to prevent progression to vision-threatening stages. These results, coupled with her presenting symptoms of numbness and tingling in the feet, suggest the development of diabetic neuropathy. The combination of these findings highlights the need for intensified control of her blood glucose levels, blood pressure, and lipid profile to mitigate the risk of further complications.

The healthcare team is now tasked with integrating these diagnostic results into a comprehensive care plan. This involves adjusting her medication regimen, possibly considering the addition of a GLP-1 receptor agonist or SGLT2 inhibitor to enhance glycemic control and provide cardiovascular benefits. The team will also need to reinforce lifestyle modifications, such as dietary changes and increased physical activity, while closely monitoring her kidney function and eye health. These steps are crucial to preventing the escalation of her diabetic complications and improving her overall quality of life.

Section 2

Response to Interventions:

In response to the diagnostic findings, the healthcare team initiated a revised treatment plan aimed at addressing the multifaceted complications of the patient's diabetes. The patient was started on an SGLT2 inhibitor, empagliflozin, to improve glycemic control and provide renal and cardiovascular protective benefits. Additionally, atorvastatin was prescribed to manage her elevated LDL cholesterol and triglycerides, targeting a more aggressive lipid management approach. The patient was also educated on the importance of adhering to a low-carbohydrate, heart-healthy diet and was encouraged to engage in moderate physical activity, such as walking or cycling, for at least 150 minutes per week.

Two weeks following these interventions, the patient returned for a follow-up visit. Her blood pressure had decreased to 128/76 mmHg, demonstrating improved cardiovascular parameters. However, she reported experiencing increased urinary frequency, a known side effect of SGLT2 inhibitors, which required careful monitoring to prevent dehydration and ensure renal function stability. Her fasting blood glucose levels had improved modestly, averaging 140 mg/dL, indicating a positive trend in glycemic control, although further adjustments might be necessary to achieve target HbA1c levels.

Despite these initial positive changes, the patient continued to experience persistent numbness and tingling in her feet, suggesting that her diabetic neuropathy needed additional attention. Consequently, the healthcare team considered the introduction of gabapentin to alleviate neuropathic symptoms, while emphasizing the importance of meticulous foot care to prevent ulcerations. These interventions, while showing promising improvements, necessitated ongoing evaluation and adjustments to optimize the patient's management plan and prevent the progression of diabetic complications. Regular follow-ups were scheduled to reassess her symptoms, review laboratory results, and refine her treatment strategy as needed.

Section 3

Two months after the initial interventions, the patient presents for a scheduled follow-up, reporting a new onset of fatigue and mild shortness of breath during her daily activities. Clinical evaluation reveals a slight increase in her blood pressure, now measuring 142/84 mmHg, suggesting the need for closer monitoring and potential adjustment of her antihypertensive regimen. On physical examination, bilateral pedal edema is noted, raising concerns for fluid retention possibly related to her diabetic nephropathy or the recent changes in medication. Her weight has increased by 3 pounds since the last visit, despite adherence to dietary recommendations, suggesting fluid accumulation rather than adiposity.

Laboratory tests were conducted to investigate these new symptoms. Her serum creatinine level has risen to 1.4 mg/dL from a baseline of 1.1 mg/dL, and her estimated glomerular filtration rate (eGFR) has decreased to 55 mL/min/1.73m², indicating a decline in renal function. Urinalysis reveals microalbuminuria, further confirming renal involvement. These findings warrant a re-evaluation of her current medications, particularly the dose of empagliflozin, given its diuretic effect, and consideration of additional nephroprotective strategies.

The healthcare team expresses concern about the progression of diabetic nephropathy and the potential impact on her cardiovascular health. They propose a comprehensive review of her treatment plan, including possible introduction of an ACE inhibitor or ARB to provide renal protection and better blood pressure control. Additionally, the team emphasizes the importance of monitoring fluid balance and encourages the patient to report any significant weight changes or worsening edema promptly. Follow-up appointments are scheduled to closely monitor her renal function and adjust therapies as needed, aiming to stabilize her condition and prevent further complications.

Section 4

Following the adjustments to her treatment plan, including the initiation of an ACE inhibitor to provide renal protection and optimize blood pressure control, the patient returns for a follow-up appointment two weeks later. She reports feeling a slight improvement in her energy levels, although she still experiences occasional mild shortness of breath during exertion. Notably, she mentions a decrease in the severity of her pedal edema, which is a positive sign, suggesting a response to the diuretic effect of the ACE inhibitor. Her weight has stabilized, indicating better fluid management. However, her blood pressure remains elevated, now reading 140/88 mmHg, signaling the need for further adjustment of her antihypertensive regimen.

New laboratory results show her serum creatinine has stabilized at 1.4 mg/dL, and while her eGFR remains at 55 mL/min/1.73m², the fact that it has not declined further is encouraging. Urinalysis still indicates microalbuminuria, but there is no significant increase in protein levels. Given these findings, the healthcare team decides to titrate the dose of her ACE inhibitor to achieve better blood pressure control and further mitigate renal risk. Additionally, they explore the possibility of introducing a low-dose diuretic to assist in managing her fluid status without compromising her renal function.

The patient is advised to continue monitoring her blood pressure and weight at home, maintaining a log to facilitate ongoing assessment. She is also counseled on the importance of adhering to her medication regimen and dietary recommendations, particularly sodium restriction, to support her cardiovascular and renal health. Scheduled follow-up visits will focus on assessing her response to the adjusted treatment plan, ensuring effective management of her diabetic nephropathy and blood pressure, and preventing the progression of her current complications.

Section 5

The patient returns for her scheduled follow-up appointment four weeks after her last visit, having adhered to the adjusted treatment plan. During the initial assessment, her blood pressure has improved slightly to 136/84 mmHg, indicating a positive response to the titrated dose of the ACE inhibitor. Her heart rate is steady at 72 beats per minute, and her respiratory rate is 18 breaths per minute, with no notable increase in exertional dyspnea. The patient reports feeling more energetic, and she confirms a substantial reduction in the frequency and severity of shortness of breath during physical activities. Notably, her home monitoring log shows consistent blood pressure readings averaging 134/82 mmHg, and her weight has remained stable, suggesting effective fluid management.

However, the clinical team notes a concerning change in her laboratory results. Her serum potassium level has increased slightly to 5.2 mEq/L, which is above the normal range, likely influenced by the addition of the low-dose diuretic in conjunction with the ACE inhibitor. While her serum creatinine remains stable at 1.4 mg/dL, and her eGFR is unchanged, the elevated potassium level necessitates further investigation and consideration of her current medication regimen. The healthcare team decides to re-evaluate her medications, considering the potential need to adjust the diuretic dose or explore alternative diuretics to manage her fluid status without exacerbating hyperkalemia.

In response to these findings, the patient is advised to continue her current dietary restrictions, with additional emphasis on limiting potassium-rich foods. She is also educated about the signs and symptoms of hyperkalemia, such as muscle weakness or palpitations, which she should report immediately. The team plans for more frequent laboratory monitoring to closely observe her kidney function and electrolyte balance, aiming to prevent any new complications while continuing to optimize her blood pressure and renal protection. The patient's next follow-up visit will focus on adjusting her treatment plan as necessary and ensuring that her diabetic nephropathy and hypertension remain well-managed.